Anticoagulant Reversal Drugs Market Value Projected to Expand by 2029
Anticoagulant reversal drugs market is anticipated to grow at a significant CAGR during the forecast period. Anticoagulant reversal drugs come in various drug classes such as prothrombin complex concentrates, coagulation factors, monoclonal antibodies, phytonadione, and other drug classes. In addition to this, the high demand for these drugs from various end-users such as hospitals, pharmacies, retail pharmacies, and others is primarily contributing to the global market growth.
The other key factors
contributing to the market growth include a surge in the global prevalence of
multiple cardiovascular indications, the increase in intracranial and
gastrointestinal haemorrhages, atrial fibrillation, and the constantly rising
geriatric population. The mortalities registered due to these diseases too is
quite high. As per the World Health Organization, each year an estimated 17.9
million people die due to cardiovascular diseases around the globe. This
further indicates the share of 35% of the global mortalities. Additionally, 85%
of these cardiovascular disease mortalities are registered due to heart attacks
and strokes.
Some key players operating in the market include
Pfizer Inc., Boehringer Ingelheim GmbH, CSL Behring Limited, Portola Pharmaceuticals
Inc., and Octapharma AG, among others. These players are eyeing to strengthen
their position in the market by adopting various strategies as mergers and
acquisitions, partnerships, collaborations, new product launch and development
in the existing product portfolio, and so on.
To Request a Sample of our Report on Anticoagulant
Reversal Drugs Market: https://www.omrglobal.com/request-sample/anticoagulant-reversal-drugs-market
Market Coverage
·
The market number available for – 2021-2029
·
Base year- 2021
·
Forecast period- 2023-2029
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: Pfizer Inc., Boehringer Ingelheim GmbH, CSL
Behring Limited, Portola Pharmaceuticals Inc., and Octapharma AG, among
others.
Anticoagulant Reversal Drugs Market by Segments
By Drug Class
• Prothrombin Complex
Concentrates
• Coagulation Factors
• Monoclonal Antibodies
• Phytonadione
• Others
By End-User
• Hospital Pharmacies
• Retail Pharmacies
• Others
A
full Report of Anticoagulant Reversal Drugs Market is Available at: https://www.omrglobal.com/industry-reports/anticoagulant-reversal-drugs-market
Anticoagulant Reversal Drugs Market
by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment